ArticleThe Journal of biological chemistry2014

A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.

Juergen M Schanzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.